Option chain shows key data for Greater Cannabis Co's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Greater Cannabis Co.

Greater Cannabis Co (OTC:GCAN) Stock, Option Chain

Greater Cannabis Co Inc is a biopharmaceutical company focused on the development and commercialization of cannabinoid therapeutics. The firm focuses on cannabis-related investment and development opportunities through direct equity investments, joint ventures, licensing agreements, or acquisitions and also on commercializing its eluting transmucosal patch platform (ETP) technology. The company's operations are focused on its online store, GCC Superstore. The firm is involved in additional research and development of cannabinoid-based therapeutics.

cannabis and pregnancy (Nataliya Vaitkevich and Dhemer Gonçalves by Pexels)

Cannabis

News

Regulations

Health Care

Politics

Legal

GCAN

Maternal marijuana use is not related to an increased risk of autism spectrum disorder (ASD) in children who were exposed to cannabis in utero. That&#39;s according to newly published data in Autism Research earlier this month. The research by experts associated with Emory University, John Hopkins, and Harvard included 11,570 children aged 1–18. The study looked at the correlation between prenatal cannabis exposure and ASD and found no link. &#34;In a large sample and measuring ASD traits continuously, there was no evidence that prenatal cannabis exposure increases the risk for ASD,&#34; the researchers concluded. &#34;Although no associations were found with ASD outcomes, prenatal cannabis exposure may still be associated with other facets of child development and behavior that were outside of the scope of this study, such as attention and cognition.&#34;

Prenatal Cannabis Exposure Not Linked To Elevated Risk Of Autism And Oklahoma Court Rules Pregnant Moms Who Use It Are Not Breaking The Law

Screenshot 2024-04-18 at 6.10.36 PM

Markets

Cannabis Holds Promise In Treating Autism: GCANRx (OTCPK: GCAN) Is Taking It To The Next Level With Its Novel Neuropsychiatric Cannabinoid Therapy

General

Ohio researchers want to learn more about the effects of medical marijuana on those with autism spectrum disorder (ASD), obsessive-compulsive disorder (OCD) and irritable bowel syndrome, reported Cleveland.com.

Can Marijuana Treat Autism, OCD &amp; Irritable Bowel Syndrome? Ohio Medical Panel Will Investigate

GREATER CANNABIS CO INC by Greater Cannabis Co Inc.

Comments

Greater Cannabis Co

Greater Cannabis Co (GCAN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga